Dr Reddy's recalls Rivastigmine Tartrate capsules of 1.5 mg strength from US

Dr Reddy's Laboratories (DRL) has initiated voluntary recall of Rivastigmine Tartrate Capsules of 1.5 mg strength from the USA market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news